Skip to main content

Politicians make promises on their stump — we watch and hold them accountable.

Help keep the record honest →Create an account
Bills/119th Congress · House

H.R. 3749

Introduced

HER Act

Sponsor
DShontel M. Brown· Ohio
Introduced
June 5, 2025
Policy area
Health
Latest action
Referred to the House Committee on Energy and Commerce.June 5, 2025

Plain-language analysis

Not yet analyzed.

A plain-language breakdown — including any hidden or off-intent provisions and whether the bill was fast-tracked — is generated separately and reviewed before publishing. It will appear here once ready. Until then, the verbatim text below and the official source are the record.

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 3749 Introduced in House (IH)] <DOC> 119th CONGRESS 1st Session H. R. 3749 To direct the Secretary of Health and Human Services to award grants for research, investigation, and awareness of the effect of personal care products containing endocrine-disrupting chemicals on the female reproductive system, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES June 5, 2025 Ms. Brown (for herself, Mrs. McIver, Mr. Johnson of Georgia, and Ms. Pressley) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To direct the Secretary of Health and Human Services to award grants for research, investigation, and awareness of the effect of personal care products containing endocrine-disrupting chemicals on the female reproductive system, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Health and Endocrine Research on personal care products for women Act'' or the ``HER Act''. SEC. 2. GRANTS FOR RESEARCH, INVESTIGATION, AND AWARENESS REGARDING ENDOCRINE-DISRUPTING CHEMICALS IN PERSONAL CARE PRODUCTS. (a) Research Grants.-- (1) In general.--The Secretary of Health and Human Services, acting through the Director of the National Institute of Environmental Health Sciences, shall award grants for research on the impact of personal care products containing endocrine-disrupting chemicals on the female reproductive system and related reproductive toxicity concerns. (2) Reports.--Not later than 5 years after the date of enactment of this Act, and every 5 years thereafter, the Secretary shall submit to the Congress, and make publicly available on the appropriate website of the Department of Health and Human Services, a report based on the results of the research under paragraph (1). Such report shall-- (A) outline research developments and findings related to disparities in access to safe non-endocrine- disrupting personal care products; (B) list safe and harmful personal care products, as determined by the Secretary; and (C) include evidence-based or evidence-informed legislative or administrative strategies to increase the Food and Drug Administration's domain to regulate personal care product ingredients that are endocrine- disrupting chemicals that harm women's reproductive health. (b) State Grants for Investigation and Awareness.-- (1) In general.--The Secretary shall award grants to States for carrying out-- (A) programs to investigate the impact of personal care products containing endocrine-disrupting chemicals on women's reproductive health; and (B) programs to develop and implement public awareness and education campaigns about the use of alternative personal care products that are less harmful to human health. (2) Reports.--Not later than 5 years after the initial awarding of grants under paragraph (1), and every 5 years thereafter, the Secretary shall submit to the Congress, and make publicly available on the appropriate website of the Department of Health and Human Services, a report summarizing the findings and results of the programs and activities funded through the grants under paragraph (1). (c) Definitions.--In this section: (1) Endocrine-disrupting chemical.--The term ``endocrine- disrupting chemical'' means a chemical that mimics, blocks, or interferes with the body's hormones. (2) Personal care product.--The term ``personal care product'' means a product that-- (A) is a cosmetic (as defined in section 201 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321)); and (B) is intended to support the hygiene, grooming, or other personal care of the human body. (3) Secretary.--The term ``Secretary'' means the Secretary of Health and Human Services. (4) State.--The term ``State'' means-- (A) each of the several States, the District of Columbia, and the territories of the United States; and (B) an Indian Tribe or Tribal organization (as such terms are defined in section 4 of the Indian Self- Determination and Education Assistance Act (25 U.S.C. 5304)). <all>

StumpWatch is live, and the record is still growing. Many promises and positions aren’t tracked yet, and some features are still in beta. Add a sourced promise and help keep the record honest.

Help keep the record honest →